Your browser is no longer supported. Please, upgrade your browser.
IQVIA Holdings Inc.
IndexS&P 500 P/E66.57 EPS (ttm)3.93 Insider Own0.72% Shs Outstand191.60M Perf Week-0.15%
Market Cap49.85B Forward P/E25.80 EPS next Y10.14 Insider Trans-29.06% Shs Float190.14M Perf Month2.78%
Income767.00M PEG3.01 EPS next Q3.17 Inst Own90.80% Short Float1.09% Perf Quarter-0.59%
Sales13.54B P/S3.68 EPS this Y49.50% Inst Trans-0.63% Short Ratio2.72 Perf Half Y12.21%
Book/sh30.06 P/B8.71 EPS next Y13.88% ROA1.70% Target Price300.22 Perf Year56.11%
Cash/sh10.03 P/C26.08 EPS next 5Y22.13% ROE6.90% 52W Range165.52 - 272.25 Perf YTD46.05%
Dividend- P/FCF24.45 EPS past 5Y-14.20% ROI3.50% 52W High-3.88% Beta1.40
Dividend %- Quick Ratio1.10 Sales past 5Y14.60% Gross Margin33.20% 52W Low58.10% ATR6.54
Employees74000 Current Ratio1.10 Sales Q/Q36.40% Oper. Margin6.20% RSI (14)53.07 Volatility2.92% 2.43%
OptionableYes Debt/Eq2.13 EPS Q/Q845.30% Profit Margin3.00% Rel Volume1.06 Prev Close262.73
ShortableYes LT Debt/Eq2.11 EarningsOct 21 BMO Payout0.00% Avg Volume765.89K Price261.68
Recom1.70 SMA200.83% SMA503.31% SMA20010.47% Volume812,937 Change-0.40%
Aug-05-21Resumed Credit Suisse Outperform $272
Apr-16-21Upgrade Stephens Equal-Weight → Overweight $180 → $250
Mar-08-21Upgrade KeyBanc Capital Markets Sector Weight → Overweight $218
Mar-03-21Initiated Barclays Overweight $220
Jul-07-20Initiated Stephens Equal-Weight $150
Mar-02-20Initiated Deutsche Bank Buy $190
Jan-08-20Initiated Wells Fargo Overweight $180
Jan-07-20Initiated Citigroup Buy $185
Dec-13-19Upgrade CFRA Sell → Hold
Nov-14-19Upgrade Wolfe Research Peer Perform → Outperform
Jun-21-19Upgrade Mizuho Neutral → Buy $150 → $175
May-28-19Initiated SVB Leerink Outperform
Jan-18-19Upgrade Jefferies Hold → Buy
Oct-09-18Initiated UBS Buy
Oct-02-18Reiterated Robert W. Baird Outperform $143 → $146
Jul-25-18Upgrade BofA/Merrill Neutral → Buy
Jul-25-18Reiterated Stifel Buy $128 → $150
Jul-03-18Upgrade Raymond James Outperform → Strong Buy
Apr-13-18Upgrade Goldman Neutral → Buy
Mar-07-18Upgrade SunTrust Hold → Buy
Dec-03-21 10:43AM  
Dec-02-21 08:00AM  
Dec-01-21 09:35AM  
Nov-26-21 08:28AM  
Nov-19-21 10:38AM  
Nov-12-21 11:26AM  
Nov-11-21 11:13AM  
Nov-10-21 09:35AM  
Nov-08-21 06:50AM  
Nov-05-21 07:28AM  
Nov-03-21 12:29PM  
Nov-01-21 12:46PM  
Oct-28-21 12:20PM  
Oct-27-21 12:29PM  
Oct-26-21 12:38PM  
Oct-22-21 12:40PM  
Oct-21-21 02:00PM  
Oct-20-21 10:22AM  
Oct-19-21 10:47AM  
Oct-12-21 03:00PM  
Oct-07-21 11:00AM  
Oct-06-21 08:00AM  
Sep-30-21 08:00AM  
Sep-28-21 10:27AM  
Sep-27-21 10:57AM  
Sep-17-21 09:31AM  
Sep-14-21 11:42AM  
Sep-13-21 04:15PM  
Sep-08-21 08:00AM  
Sep-07-21 08:25AM  
Sep-02-21 04:15PM  
Sep-01-21 08:00AM  
Aug-26-21 11:31AM  
Aug-20-21 11:06AM  
Aug-04-21 05:44PM  
Aug-02-21 04:19AM  
Jul-27-21 02:31PM  
Jul-23-21 09:57AM  
Jul-22-21 08:00PM  
Jul-21-21 09:26AM  
Jul-20-21 03:01PM  
Jul-13-21 04:15PM  
Jul-07-21 10:40AM  
Jul-03-21 05:03AM  
Jul-02-21 09:02AM  
Jun-25-21 10:52AM  
Jun-24-21 04:15PM  
Jun-15-21 08:00AM  
Jun-14-21 08:00AM  
Jun-08-21 10:25AM  
Jun-03-21 04:30PM  
May-28-21 04:22AM  
May-24-21 04:36PM  
May-22-21 08:00AM  
May-21-21 07:00AM  
May-20-21 04:15PM  
May-19-21 08:00AM  
May-18-21 02:40PM  
May-17-21 04:22PM  
May-11-21 09:03AM  
May-10-21 08:00AM  
May-03-21 12:45PM  
Apr-29-21 08:00AM  
Apr-28-21 08:00AM  
Apr-23-21 09:15AM  
Apr-22-21 03:30PM  
Apr-20-21 08:33AM  
Apr-07-21 02:23PM  
Apr-06-21 01:00PM  
Apr-05-21 09:49AM  
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CONNAUGHTON JOHNDirectorNov 29Sale262.60555,094145,767,68462,390Dec 01 06:02 PM
Knightly Kevin CSee RemarksAug 16Sale250.006,0551,513,7502,006Aug 18 05:00 PM
DANHAKL JOHN GDirectorDec 23Buy176.9563,45111,227,654137,410Dec 28 05:07 PM